📜十一烷酸置于戊醇,Sodium,Thorium Dioxide体系中,化学反应生成2-十三醇 参考文献:Dominant Role Of An Endothelium-Derived Hyperpolarizing Factor (Edhf)-Like Vasodilator In The Ciliary Vascular Bed Of The Bovine Isolated Perfused Eye 标题:Dominant Role Of An Endothelium-Derived Hyperpolarizing Factor (Edhf)-Like Vasodilator In The Ciliary Vascular Bed Of The Bovine Isolated Perfused Eye 摘要:以下是中文翻译: 评估了来自内皮的no,前列环素和内皮源性超极化因子(edhf)在介导乙酰胆碱和缓激肽引发的血管舒张反应中的作用,实验对象为牛孤立灌注眼的睫状血管床. 乙酰胆碱或缓激肽引起的血管舒张不受no合成酶抑制剂(l-Name,100 μm)或环氧化酶抑制剂(flurbiprofen,30 μm)的影响,但在给予高浓度kcl(30 Mm)或使用洗涤剂chaps(0.3%,2 Min)破坏内皮后,血管舒张几乎完全消失. 乙酰胆碱诱导的血管舒张不受atp敏感型k+通道抑制剂(glibenclamide,10 μm)的影响,但在给予非选择性k+通道抑制剂(tea,10 Mm)后显著减弱. 小导电钙敏感型k+通道(sk+ca)抑制剂(apamin,100 Nm)和大导电钙敏感型k+通道(bk+ca)抑制剂(iberiotoxin,50 Nm)对乙酰胆碱诱导的血管舒张无显著影响.相比之下,中/大导电钙敏感型k+通道抑制剂(charybdotoxin,50 Nm)强烈阻断了这些血管舒张反应,并揭示了血管收缩反应. Apamin(100 Nm)与sub-Threshold浓度的charybdotoxin(10 Nm)组合显著减弱乙酰胆碱诱导的血管舒张,而apamin(100 Nm)与iberiotoxin(50 Nm)组合无影响. 综上所述,高浓度kcl,Charybdotoxin或apamin与sub-Threshold浓度charybdotoxin的组合对血管舒张的强烈阻断,强烈表明牛孤立灌注眼中的血管舒张是由edhf介导的. British Journal Of Pharmacology (2001) 134,912-920; Doi:10.1038/sj.Bjp.0704332 Doi:10.1038/sj.Bjp.0704332
专利号:US-6384228-B2 优先权日:1998-05-26 标题 :Method for synthesis of halopyridyl-azacyclopentane derivative and intermediate thereof 发明人:NODE MANABU; NAKAMURA DAISAKU; FUJIWARA TOSHIO; ICHIHASHI SHOGO 权利人:NIHON MEDIPHYSICS CO LTD 摘要:The present invention relates to a method for synthesis of an optically active halopyridyl-azacyclo-pentane derivative and the intermediate thereof which comprises preparing an optically active allene-1,3-dicarboxylic acid ester derivative from an optically active acetonedicarboxylic acid ester derivative and then proceeding through a 7-azabicyclo[2.2.1]heptane derivative to obtain the objective product.
专利号:WO-2014108526-A1 优先权日:2013-01-11 标题 :Synthetic process for the manufacture of pipecolidepsin compounds 发明人:PELAY GIMENO MARTA; GARCÃ?A-RAMOS YESICA; TULLA PUCHE JUDIT; ALBERICIO PALOMERA FERNANDO; MARTÃ?N LÓPEZ M JES S 权利人:PHARMA MAR SA 摘要:(I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , n and Y are as described. The invention provides a process for the synthesis of complex pipecolidepsin and related compounds of formula (I), opening a new field of compounds with useful biological properties. The invention also provides intermediates, useful in the synthesis of compounds of formula (I).
专利号:US-10017465-B2 优先权日:2014-08-12 标 题 :Method for producing astaxanthin from astacin 发明人:Schäfer Bernd; SIEGEL WOLFGANG 权利人:BASF SE 摘要:The invention relates to a method for the non-stereoselective and also for the stereoselective synthesis of astaxanthin from astacin. For this purpose, a reducing agent is used selected from the group of hydrogen, a secondary alcohol, formic acid and also the salts of formic acid or from a mixture of at least two representatives of the compound classes stated above. The invention further relates to the use of astacin as starting compound for the synthesis of astaxanthin.
专利号:US-2002010339-A1 优先权日:1998-05-26 标 题:Method for synthesis of halopyridyl-acyclopentane derivative and intermediate thereof
专利号:CN-102924707-A 优先权日:2012-11-22 标 题 :Catalyst for Synthesis of Block Polyether and Its Application
专利号:CN-102924709-B 优先权日:2012-11-22 标题:The method of synthesis block polyether
参考文献:10.1007/s11694-025-03802-9 摘要:Dharmaraj S, Veerapandian C, Vijayaram E, Nagarethinam B, Sivanandham V. Characterization of physicochemical properties and volatile compounds profiles of Shevaroy coffee during ripening and identification of volatile compound biomarkers. Food Measure. 2025 Nov 21;20(2):1912–30. doi: 10.1007/s11694-025-03802-9.